1. Home
  2. Labeler Index
  3. Allermed Laboratories, Inc.
  4. NDC Product Code: 49643-315 Short Ragweed

NDC 49643-315 Short Ragweed

View Dosage, Usage, Ingredients, Routes, UNII

Table of Contents

  1. Product Information
  2. Product Packages
  3. What is NDC 49643-315?
  4. Short Ragweed Uses
  5. Active Ingredients UNII Codes
  6. Inactive Ingredients UNII Codes
  7. NDC to RxNorm Crosswalk

Product Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.
NDC Product Code:
49643-315
Proprietary Name:
Short Ragweed
Product Type: [3]
INACTIVATED PRODUCT and EXCLUDED the from NDC Directory
Labeler Name: [5]
Allermed Laboratories, Inc.
Labeler Code:
49643
Product Label ID:
1482f8a2-c2c0-45a1-8e90-b427227f0b28
Start Marketing Date: [9]
03-22-1982
Listing Expiration Date: [11]
12-31-2022
Exclude Flag: [12]
I
Code Navigator:

Code Structure Chart

Product Details

What is NDC 49643-315?

The NDC code 49643-315 is assigned by the FDA to the product Short Ragweed which is product labeled by Allermed Laboratories, Inc.. The product's dosage form is . The product is distributed in 4 packages with assigned NDC codes 49643-315-05 5 ml in 1 vial, multi-dose , 49643-315-10 10 ml in 1 vial, multi-dose , 49643-315-30 30 ml in 1 vial, multi-dose , 49643-315-50 50 ml in 1 vial, multi-dose . This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

What are the uses for Short Ragweed?

Studies have shown that properly performed an interpreted skin tests with ragweed pollen extract are useful in the diagnosis of allergy to ragweed pollen 7, 8, 20, 21. Immunotherapy with the appropriate dosage of short ragweed pollen extract is effective in reducing symptoms of hay fever and asthma resulting from exposure to short ragweed pollen (9, 10, 11), and it is believed to be effective with extract of giant ragweed, although carefully controlled studies are unavailable. However, clinical observations and known cross reactivity between short and giant ragweed pollens have led to the practice of using a mixture of the two species for skin testing and treatment 22, 23, 24, 25, 26, 27. This form of treatment is recommended for patients who cannot avoid exposure to pollen and who do not obtain satisfactory relief of symptoms from other medications, such as antihistamines. Immunologic changes resulting from treatment with short ragweed pollen extract are believed to include: The induction of specific anti-ragweed IgG antibodies commonly referred to as "blocking antibodies" 12, 13. A decrease in the elevation of ragweed specific IgE during and immediately following the ragweed pollen season 14. A reduction of circulating anti-ragweed IgE after long-term immunotherapy 15. A decrease in skin reactivity to the extract 16 and a decrease in leukocyte sensitivity to histamine release 17 after long-term immunotherapy.

Which are Short Ragweed UNII Codes?

The UNII codes for the active ingredients in this product are:

  • AMBROSIA ARTEMISIIFOLIA POLLEN (UNII: K20Y81ACO3)
  • AMBROSIA ARTEMISIIFOLIA POLLEN (UNII: K20Y81ACO3) (Active Moiety)

Which are Short Ragweed Inactive Ingredients UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

What is the NDC to RxNorm Crosswalk for Short Ragweed?

RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
  • RxCUI: 896140 - short ragweed pollen extract 100 MG/ML Injectable Solution
  • RxCUI: 896140 - Ambrosia artemisiifolia pollen extract 1 GM per 10 ML Injectable Solution
  • RxCUI: 896140 - Ambrosia artemisiifolia pollen extract 100 MG/ML Injectable Solution

* Please review the disclaimer below.

Product Footnotes

[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".